Christoph A. Baus

Partner

Frankfurt / Hamburg
christoph.baus@lw.com
+49.69.6062.6000

PRACTICES

  • Complex Commercial Litigation
  • Insurance Counseling & Recovery
  • International Arbitration
  • Litigation & Trial
  • Public Company Representation
  • Securities Litigation & Professional Liability
  • White Collar Defense & Investigations

INDUSTRIES

  • Aerospace, Defense & Government Services
  • Automotive
  • Energy & Infrastructure
  • Entertainment, Sports & Media
  • Financial Institutions

BAR QUALIFICATIONS

  • Rechtsanwalt (Germany)

EDUCATION

  • Second German State Exam, Higher Regional Court, Braunschweig,
  • Dr. jur., University of Goettingen,
  • First German State Exam, University of Goettingen,

LANGUAGES SPOKEN

  • English
  • German

PROFILE

Dr. Christoph Baus, a complex commercial trial lawyer, has served as Global Vice Chair of the firm’s Litigation & Trial Department and Regional Chair of the Litigation & Trial Department in continental Europe. 

Christoph represents clients at trial and in arbitration in a range of disputes, related to: 

  • Complex commercial 
  • Securities
  • Professional liability 
  • Shareholders 
  • M&A  
  • Insolvency  
  • Antitrust damages and abuse of dominance 

Christoph has unparalleled experience in courtrooms and has led some of the most complex and high-profile cases, including Germany’s largest mass securities litigation matter. He is regularly lauded by leading legal publications, including JUVE, The Legal 500, and Chambers Europe, and has been compared to Cicero and James Bond.

EXPERIENCE

Christoph’s representative experience includes advising: 

Mass Actions and Securities Litigation

  • DAX 30 company in German and US securities litigation
  • Scottish Widows Limited in connection with the alleged misselling of insurance policies 
  • Scholz Holding AG in securities litigation
  • Leading international financial institution in thousands of customer claims

M&A Litigation/Arbitration

  • Rhön Klinikum AG to secure €3.07 billion sale of healthcare institutions to Helios, subsidiary of Fresenius Medical Care
  • European private equity house in post-M&A ICC arbitration
  • UK public company in post-M&A arbitration
  • Hamburg new economy company in post-M&A DIS arbitration with US corporation

Commercial and Antitrust Disputes

  • DAX 30 company in cartel damages cases from various world-wide cartels
  • Main shareholder in European pharma enterprise in shareholder arbitration
  • Main shareholder in German partnership (ship management) in €2 billion shareholder arbitration
  • Leading consumer company in a series of competition-related claims against a competitor 
  • International cable company in abuse of dominance case